Cyclopharm Limited (AU:CYC) has released an update.
David James Heaney, a director at Cyclopharm Limited, has increased his stake in the company by purchasing 21,126 ordinary shares for a total consideration of $30,000, resulting in a new total holding of 301,126 shares. This transaction, executed under the company’s Share Purchase Plan, reflects a positive change in the director’s interest and was not conducted during a closed period requiring prior written clearance.
For further insights into AU:CYC stock, check out TipRanks’ Stock Analysis page.
